Skip to main content
. 2021 Apr 1;12(4):337. doi: 10.1038/s41419-021-03630-x

Fig. 2. HOXC6 did not alter proliferation ability of HCT116 and HT29 cells in vitro and in vivo.

Fig. 2

A Expression of HOXC6 in six CRC cell lines. B Identification of stable HOXC6 overexpression and knockdown in HCT116 cell lines using qRT-PCR. C Identification of stable HOXC6 overexpression and knockdown in RKO cell lines using qRT-PCR. D Growth curves of HCT116 cells in the NC, HOXC6-OE and HOXC6-KD groups. E Growth curves of RKO cells in the NC, HOXC6-OE and HOXC6-KD groups. F The subcutaneous NC HCT116 tumor cell injection mice. G The subcutaneous HOXC6-KD HCT116 tumor cell injection mice. H The subcutaneous HOXC6-OE HCT116 tumor cell injection mice. I The tumors dissected from NC, HOXC6-KD and HOXC6-OE mice. J The tumor wight for dissected tumors from NC, HOXC6-KD and HOXC6-OE mice groups. K The tumor growth curve evaluated by tumor long*short diameter for NC, HOXC6-KD and HOXC6-OE groups. *P < 0.05; ***P < 0.001; n.s.: no significance.